Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

Pharma Tech

ESMO26: Oral cell cycle inhibitors place Cyclin E1 as new target in PROC

Oct 25, 2026, 7:24 AM

Read Full Article → ESMO26: Oral cell cycle inhibitors place Cyclin E1 as new target in PROC

ESMO26: Oral cell cycle inhibitors place Cyclin E1 as new target in PROC

Translate article text

Choose a language and wait for the translated text.

Data for the two PROC candidates that act on Cyclin E1 were presented at ESMO26.

ESMO26: Oral cell cycle inhibitors place Cyclin E1 as new target in PROC | PharmaVoice